Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western IndiaResearch in context

• Autori principali: Atul Sajgure (Autore), Ajit Kulkarni (Autore), Atul Joshi (Autore), Vasanti Sajgure (Autore), Vaishali Pathak (Autore), Rashida Melinkeri (Autore), Shilpa Pathak (Autore), Sumit Agrawal (Autore), Manoj Naik (Autore), Milind Rajurkar (Autore), Ameya Sajgure (Autore), Girish Date (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2023-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Summary: Background: Antivirals and immunosuppressive agents are used with variable success in the treatment of COVID-19. Mycophenolate, an inhibitor of enzyme inosine monophosphate dehydrogenase, is an immunosuppressant used to prevent allograft rejection and other autoimmune diseases. Few laborato...